FDA Authorizes Use Of First Device To Treat Patients With Dialysis-Related Amyloidosis

The U.S. Food and Drug Administration recently authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat dialysis-related amyloidosis (DRA).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news